| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.01 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.01 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
| mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.41 |
0.01 |
| mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.37 |
0.01 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |